Subscriptions are live: We're on the subscription model now, early-access price $24.99/month, with day, week, and longer plans too. New accounts start with 5 free premium days. Prefer to donate? Donations grant premium time and are logged on your profile page.

$ARTV

Artiva Biotherapeutics, Inc. Common Stock

XNAS

$9.73+4.06%+$0.3800Prev $9.35LIVE Full chart Live alerts
No recent price bars, the chart lights up when ARTV starts printing.

As of the latest tick, ARTV is trading at $9.73, up 4.06% versus the previous close of $9.35.

Key Stats

Price & performance
Price
$9.73
Change today
+4.06%
Previous close
$9.35
52-week range
$2.07 – $14.53
Valuation & dividend
Market cap
$454M
Ownership & volume
Shares outstanding
24.7M
SEC 10-Q · May 8, 2026
Institutional own.
35.15%
Avg daily volume
991K
Next earnings
Aug 5 · in 21d
Classification
Exchange
XNAS

Why is $ARTV up today?

1 alert today8.9x RVOL

ARTV is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on ARTV today, peaking at 8.9x its normal volume.

Likely catalystListing deficiency / delisting risk, from the latest SEC filing. Read it →
Why is $ARTV moving? →▶ Replay the moveAuto-generated from live scanner data. Not investment advice.
Trading profileShortableEasy to borrowNo SSRBorrow via Alpaca · SSR from Reg SHO 201
Wall Street consensusStrong Buy5 analysts
Avg target $35.80(+268% upside)
Range $23 – $41
5 buy0 hold0 sell

Analyst data via Nasdaq. Not investment advice.

Insiders

Insiders buying10 open-market buys14 buys, 5 sells last 3 months (24/23 over 12 months)
Show 12 recent transactions
InsiderActionShares% of positionOwns afterValueDate
Ra Capital Management, L.P.
Director
Bought (open market)+7K
0.01% of company
added <0.1%17.98M$59K
at $8.94
Jul 13, 26
Ra Capital Management, L.P.
Director
Bought (open market)+15K
0.03% of company
added <0.1%16.81M$135K
at $8.97
Jul 10, 26
Ra Capital Management, L.P.
Director
Bought (open market)+2Kadded <0.1%17.96M$17K
at $8.98
Jun 26, 26
Ra Capital Management, L.P.
Director
Bought (open market)+31K
0.06% of company
added 0.2%16.79M$275K
at $8.88
Jun 25, 26
Ra Capital Management, L.P.
Director
Bought (open market)+125K
0.3% of company
added 0.7%17.92M$1.1M
at $8.89
Jun 16, 26
Ra Capital Management, L.P.
Director
Bought (open market)+15K
0.03% of company
added <0.1%16.64M$139K
at $8.99
Jun 15, 26
Ra Capital Management, L.P.
Director
Bought (open market)+391K
0.8% of company
added 2.4%16.62M$3.4M
at $8.57
Jun 12, 26
Ra Capital Management, L.P.
Director
Bought (open market)+549K
1.1% of company
added 3.3%17.39M$4.3M
at $7.91
Jun 11, 26
Ra Capital Management, L.P.
Director
Bought (open market)+103added <0.1%15.68M$721
at $7.00
Jun 10, 26
Ra Capital Management, L.P.
Director
Bought (open market)+479K
1.0% of company
added 3.2%15.68M$3.3M
at $6.91
Jun 9, 26
Aslan Fred
Officer
Sold (automatic/other)-27K
0.06% of company
sold 1.7%1.54M$244K
at $9.01
May 19, 26
Banerjee Subhashis
Officer
Sold (automatic/other)-7K
0.01% of company
sold 4.6%145K$63K
at $9.01
May 19, 26

Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.

Dilution watch

Recent offering

Recent priced share offering on file — new shares were sold (a completed event, not necessarily ongoing). If $ARTV runs, these filings show who may be positioned to sell new or newly-registered shares into the move.

Sourced from SEC EDGAR filings. Offering terms are read straight from the filing text where available. We flag by form type and recency (last 9 months): a shelf (S-3) stays active for ~3 years and lets the company issue on demand, while a priced 424B offering is a one-time, completed event. Form type signals dilution capacity, not an exact share count, and we do not confirm how much of a shelf remains unused. Not investment advice.

$ARTV Sentiment

Bullish
Bearish89Bullish
📰 News: 4 bull · 0 bearToday: +4.1%👥 Community: 0 bull · 0 bear

Blend of news sentiment, today’s move, and community votes. Not investment advice.

$ARTV Activity

News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.

Alert· 6h ago +4.3% vs EMA
ARTV 200EMA (1m) Trending · 60 bars · L3 · +4.30% above EMA · slope +0.40%
at $9.95
Alert· 11h ago -1.18%
$ARTV moved -1.18% in 1 min (Level 1) at 10:59 AM ET
at $9.46
Alert· 2d ago -1.15%
$ARTV moved -1.15% in 1 min (Level 1) at 4:29 PM ET
at $8.70
Alert· 2d ago 2.0× RVOL
ARTV hit 2.000x RVOL at 3:25 PM ET
at $8.86
Alert· 2d ago +1.64%
$ARTV moved +1.64% in 1 min (Level 1) at 12:32 PM ET
at $8.97
Alert· 2d ago -1.7% vs EMA
$ARTV near 200 EMA: -1.74% from 200 EMA at 12:32 PM ET
at $8.97
Alert· 2d ago 4.0× RVOL
ARTV hit 4.034x RVOL at 12:32 PM ET
at $8.97
Alert· 2d ago 2.6× RVOL
ARTV hit 2.611x RVOL at 11:16 AM ET
at $9.06
News· SEC EDGAR· 57d ago
Artiva Biotherapeutics, Inc. filed an 8-K: Executive / Board Change
News· GlobeNewswire Inc.· 57d ago Bullish
Artiva Biotherapeutics Appoints Veteran Biotech Executive and Drug Developer Diego Miralles, M.D., as President and Head of Research and Development
News· SEC EDGAR· 68d ago
Artiva Biotherapeutics, Inc. filed an 8-K: Other Material Event
News· SEC EDGAR· 68d ago
Artiva Biotherapeutics, Inc. filed a Quarterly report (10-Q)
News· SEC EDGAR· 68d ago
Artiva Biotherapeutics, Inc. filed an 8-K: Results of Operations, Regulation FD Disclosure, Other Material Event
News· GlobeNewswire Inc.· 78d ago Bullish
Rheumatoid Arthritis Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 75+ Leading Players Wheeling the Therapeutics Landscape
News· GlobeNewswire Inc.· 98d ago Bullish
Artiva Biotherapeutics to Participate in the 25th Annual Needham Virtual Healthcare Conference
News· GlobeNewswire Inc.· 141d ago Bullish
Artiva Biotherapeutics Announces Appointment of Thad Huston as Chief Financial Officer and Award of Inducement Grant

Also moving today

The tickers our scanner is lighting up most over the last 48 hours.

Free alerts

Get free $ARTV alerts the moment volume spikes

Our scanner flagged $ARTV 6 times in the last 30 days. Create a free account to track $ARTV, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.

Real-time RVOL & momentum alerts Personal watchlist & price alerts
Sign up free with email

No card · 5 premium days · join 800+ traders

ARTV stock FAQ

Why is $ARTV up today?

ARTV is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on ARTV today, peaking at 8.9x its normal volume.

What is the ARTV stock price today?

ARTV last traded at $9.73, up 4.06% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).

Where can I see live ARTV alerts?

The ARTV Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ARTV 6 times in the last 30 days.

What exchange is ARTV on?

ARTV (Artiva Biotherapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $454M.

Is ARTV good for day trading?

That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ARTV for yourself. This is not investment advice.

Live data from TheDesperateTrader scanner. Not investment advice.